GRAIL, Inc. Common Stock GRAL
$121.35
-3.41%
at last close
Market Cap$5.65 billion
P/E Ratio—
Div Yield—
Volume596.9K
52-Week Range
$41.50$166.47
Analyst Ratings
- Consensus
- Moderate Buy — 5 Buy · 5 Hold · 0 Sell (10 analysts)
- Avg. Price Target
- $128.80 (+6.1% upside)
Key Stats
- Today's Range
- $115.28 – $122.68
- 50-Day Range
- $73.46 – $166.47
- 52-Week Range
- $41.50 – $166.47
- Volume
- 597K shs
- Average Volume
- 969K shs
- Market Cap
- $5.65 billion
- P/E Ratio
- —
- Dividend Yield
- —
Short Interest
- Short Interest
- 5.08%
- Days to Cover
- 1.00
About GRAIL, Inc. Common Stock
GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection. The company has developed a multi-cancer early detection blood test that has the ability to detect all types of cancer, across all stages. It operates in one reportable operating segment which provides multi-cancer early detection testing and service.
Related Stocks
Compare head-to-head: GRAL vs NTRA·GRAL vs DGX·GRAL vs CAI·GRAL vs BLLN
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.